In-Patient PPS, "Inherent Reasonableness" Rulemaking Changes Sought
This article was originally published in The Gray Sheet
Executive Summary
Devices used in low-volume medical procedures should be guaranteed adequate payments under HCFA's implementation of an in-patient prospective payment system for new technologies, AdvaMed is urging the agency.
You may also be interested in...
HCFA Legislative Authority To Contract CABG Providers Urged By HHS OIG
Legislation should be enacted to allow the Health Care Financing Administration to negotiate preferred providers and fixed-price packages for bypass surgery for Medicare patients, the HHS Office of the Inspector General concludes in "The 2001 Red Book," a list of cost-saving recommendations that have yet to be implemented.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.